These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 36914370)

  • 1. SARS-CoV-2 vaccination status and adverse events among patients with psoriasis-Data from the German Registries PsoBest and CoronaBest.
    Valencia López MJ; Meineke A; Stephan B; Rustenbach SJ; Kis A; Thaçi D; Mrowietz U; Reich K; Staubach-Renz P; von Kiedrowski R; Bogena H; Augustin M
    J Eur Acad Dermatol Venereol; 2023 Jul; 37(7):e831-e833. PubMed ID: 36914370
    [No Abstract]   [Full Text] [Related]  

  • 2. SARS-CoV-2 infection among psoriasis patients in Germany: Data from the German registries PsoBest and CoronaBest.
    López MJV; Meineke A; Stephan B; Rustenbach SJ; Kis A; Thaçi D; Mrowietz U; Reich K; Staubach-Renz P; von Kiedrowski R; Bogena H; Augustin M
    J Dtsch Dermatol Ges; 2024 Jul; 22(7):965-972. PubMed ID: 38778439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perception and Impact of COVID-19 Pandemic in Psoriasis Patients: Data from the German PsoBest and the CoronaBest Registries.
    Valencia López MJ; Stephan B; Meineke A; Wolf S; Thaci D; Mrowietz U; Andrees V; Rustenbach SJ; Reich K; Thalmann L; Bogena H; Staubach P; von Kiedrowski RM; Augustin M
    Psoriasis (Auckl); 2024; 14():29-38. PubMed ID: 38765188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Argentinean cohort of patients with rheumatic and immune-mediated diseases vaccinated for SARS-CoV-2: the SAR-CoVAC Registry-protocol and preliminary data.
    Isnardi CA; Schneeberger EE; Kreimer JL; Luna PC; Echeverría C; Roberts K; de la Vega MC; Virasoro BM; Landi M; Quintana R; Exeni MED; Kogan N; Petkovic I; Pereira D; De Los Ángeles Correa M; Zelaya MD; Tissera Y; Elkin MSG; Pisoni CN; Alonso C; Cogo AK; Cosatti MA; García L; Retamozo C; de Los Ángeles Severina M; Nieto RE; Rosemffet M; Mussano E; Bertoli A; Savio VG; Cosentino V; Pons-Estel GJ
    Clin Rheumatol; 2022 Oct; 41(10):3199-3209. PubMed ID: 35760939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 vaccination and practical points in psoriasis patients: A narrative review.
    Aryanian Z; Balighi K; Hatami P; Goodarzi A; Mohandesi NA; Afshar ZM
    Dermatol Ther; 2022 May; 35(5):e15430. PubMed ID: 35261123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [BIOLOGICAL TREATMENT OF PSORIASIS IN TIME OF NEW CORONAVIRUS INFECTION COVID-19].
    Kruglova LS; Pereverzina NO; Rudneva NS; Kamynina NN; Oynotkinova OS
    Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2021 Aug; 29(Special Issue):1381-1387. PubMed ID: 34792893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythrodermic psoriasis eruption associated with SARS-CoV-2 vaccination.
    Nia AM; Silva MM; Spaude J; Gonzalez-Fraga JD
    Dermatol Ther; 2022 May; 35(5):e15380. PubMed ID: 35170153
    [No Abstract]   [Full Text] [Related]  

  • 8. Insights into Sars-CoV-2 vaccination in patients with chronic plaque psoriasis on systemic treatments.
    Gisondi P; Geat D; Naldi L; Piaserico S
    J Eur Acad Dermatol Venereol; 2021 Jun; 35(6):e361-e362. PubMed ID: 33650226
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety of COVID-19 vaccines in patients with psoriasis undergoing therapy with anti-interleukin agents.
    Talamonti M; Galluzzo M
    Expert Opin Biol Ther; 2021 Nov; 21(11):1535-1537. PubMed ID: 34357839
    [No Abstract]   [Full Text] [Related]  

  • 10. Coronavirus disease 2019 vaccination in patients with psoriasis: A position statement from India by SIG psoriasis (IADVL Academy).
    Parthasaradhi A; Ganguly S; Kar BR; Thomas J; Neema S; Tahiliani S; Sathishkumar D; Parasramani SG; Chalam KV; Komeravalli H
    Indian J Dermatol Venereol Leprol; 2022; 88(3):286-290. PubMed ID: 35434988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psoriasis exacerbation after COVID-19 vaccination: a report of 14 cases from a single centre.
    Sotiriou E; Tsentemeidou A; Bakirtzi K; Lallas A; Ioannides D; Vakirlis E
    J Eur Acad Dermatol Venereol; 2021 Dec; 35(12):e857-e859. PubMed ID: 34363647
    [No Abstract]   [Full Text] [Related]  

  • 12. New onset of mainly guttate psoriasis after COVID-19 vaccination: a case report.
    Lehmann M; Schorno P; Hunger RE; Heidemeyer K; Feldmeyer L; Yawalkar N
    J Eur Acad Dermatol Venereol; 2021 Nov; 35(11):e752-e755. PubMed ID: 34309932
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply to "Psoriasis exacerbation after COVID-19 vaccination: report of 14 cases from a single centre" by Sotiriou E et al.
    Megna M; Potestio L; Gallo L; Caiazzo G; Ruggiero A; Fabbrocini G
    J Eur Acad Dermatol Venereol; 2022 Jan; 36(1):e11-e13. PubMed ID: 34534379
    [No Abstract]   [Full Text] [Related]  

  • 14. New onset of remitting seronegative symmetrical synovitis with pitting oedema and palmoplantar psoriasis flare-up after Sars-Cov-2 vaccination.
    Quattrini L; Verardi L; Caldarola G; Peluso G; De Simone C; D'Agostino M
    J Eur Acad Dermatol Venereol; 2021 Nov; 35(11):e727-e729. PubMed ID: 34236728
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety of SARS-CoV-2 vaccines in psoriatic patients treated with biologics: A real life experience.
    Musumeci ML; Caruso G; Trecarichi AC; Micali G
    Dermatol Ther; 2022 Jan; 35(1):e15177. PubMed ID: 34699117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of COVID-19 vaccines in multiple sclerosis: A systematic review and meta-analysis.
    Stefanou MI; Palaiodimou L; Theodorou A; Christodoulou MV; Tzartos JS; Tzanetakos D; Kitsos D; Chondrogianni M; Zouvelou V; Dardiotis E; Tzavellas E; Syrigou E; Benetou V; Paraskevas GP; Tsiodras S; Tsivgoulis G; Giannopoulos S
    Mult Scler; 2023 Apr; 29(4-5):585-594. PubMed ID: 36722184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse Events Following One Dose of mRNA COVID-19 Vaccination Among US Nursing Home Residents With and Without a Previous SARS-CoV-2 Infection.
    Bardenheier BH; Gravenstein S; Blackman C; Gutman R; Sarkar IN; Feifer RA; White EM; McConeghy K; Nanda A; Bosco E; Mor V
    J Am Med Dir Assoc; 2021 Nov; 22(11):2228-2232. PubMed ID: 34534492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 vaccination intention among patients with psoriasis compared with immunosuppressed patients with other skin diseases and factors influencing their decision.
    Sotiriou E; Bakirtzi K; Papadimitriou I; Paschou E; Vakirlis E; Lallas A; Ioannides D
    Br J Dermatol; 2021 Jul; 185(1):209-210. PubMed ID: 33609286
    [No Abstract]   [Full Text] [Related]  

  • 20. Exacerbation of psoriasis following COVID-19 vaccination in a patient previously treated with PD-1 inhibitor.
    Mieczkowska K; Kaubisch A; McLellan BN
    Dermatol Ther; 2021 Sep; 34(5):e15055. PubMed ID: 34231301
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.